Treatment of pneumococcal pneumonia: The case for penicillin G

American Journal of Medicine

Volumn 107, Issue 1 A, 1999, Pages 63-68

  Bryan, Charles S ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G; VANCOMYCIN;

BLEEDING TENDENCY; CONFERENCE PAPER; DOSE RESPONSE; HUMAN; LOBAR PNEUMONIA; MINIMUM INHIBITORY CONCENTRATION; NEUROTOXICITY; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

EID: 0033606810     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(99)00099-6     Document Type: Conference Paper

References (73)

1. Neel J.V. Looking ahead some genetic issues of the future . Perspect Biol Med. 40:1997;329-347.
2. Tillett W.S., McCormack J.E., Cambier M.J. The treatment of lobar pneumonia with penicillin. J Clin Invest. 24:1945;589-594.
3. Meads M., Harris H.W., Finland M. Treatment of pneumococcal pneumonia with penicillin. N Engl J Med. 232:1945;747-755.
4. Collen M.F., Sellers A.L. Penicillin therapy in pneumococcic pneumonia a preliminary report . Permanente Found Med Bull. 3:1945;49-55.
5. White W.L., Murphy F.D., Lockwood J.S., Flippin H.F. Penicillin in the treatment of pneumococcal, meningococcal, streptococcal and staphylococcal meningitis. Am J Med Sci. 210:1945;1-17.
6. Sweet L.K., Dumoff-Stanley E., Dowling H.F., Lepper M.H. The treatment of pneumococcic meningitis with penicillin. JAMA. 127:1945;263-267.
7. Appelbaum E., Nelson J. Penicillin in the treatment of pneumococcic meningitis. JAMA. 128:1945;778-781.
8. Bunn P.A., McDermott W., Hadley S.J., Carter A.C. The treatment of pneumococcic pneumonia with orally administered penicillin. JAMA. 129:1945;320-327.
9. Austrian R., Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med. 60:1964;759-776.
10. Dauer C.C. A demographic analysis of recent changes in mortality, morbidity, and age group distribution in our population. Galdston I. The Impact of the Antibiotics on Medicine and Society. 1958;98-120 International Universities Press, New York.
11. Shorter E. Doctors and Their Patients A Social History . 1993;21-22 Transaction Publishers, New Brunswick, NJ.
12. Kunin C.M. Resistance to antimicrobial drugs a worldwide calamity. Ann Intern Med. 118:1993;557-561.
13. Bryan C.S., Talwani R., Stinson M.S. Penicillin dosing for pneumococcal pneumonia. Chest. 112:1997;1657-1664.
14. Rammelkamp C.H., Keefer C.S. The absorption, excretion, and distribution of penicillin. J Clin Invest. 22:1943;425-437.
15. Tillett W.S., Cambier M.J., McCormack J.E. The treatment of lobar pneumonia and pneumococcal empyema with penicillin. Bull N Y Acad Med. 20:1944;142-178.
16. Dowling H.F., Rotman-Kavka G., Hussey H.H., Hirsh H.L. The treatment of pneumococcic pneumonia with oral and intramuscular penicillin. Am J Med Sci. 213:1947;413-417.
17. Price A.H. Aqueous penicillin therapy for pneumococcic pneumonia. JAMA. 138:1948;292-293.
18. Tumulty P.A., Zubrod G. Pneumococcal pneumonia treated with aqueous penicillin at twelve-hour intervals. N Engl J Med. 239:1948;1033-1036.
19. Hamburger M., Berman J., Thompson R.T., Blankenhorn M.A. The treatment of pneumococcal pneumonia by penicillin in aqueous solution at long intervals. J Lab Clin Med. 34:1949;59-66.
20. Neu H.C. Pneumonia. Stein J.H. Internal Medicine. 4th ed. 1994;1868-1887 Mosby, St. Louis.
21. Greenwood B.M. Pneumococcal infection. Weatherall D.J., Ledingham J.G.G., Warrell D.A. Oxford Textbook of Medicine. 3rd ed. 1996;511-523 Oxford University Press, Oxford.
22. Henkel T.J., Fraser V.J. Treatment of infectious diseases. Ewald G.A., McKenzie C.R. Manual of Medical Therapeutics. 28th ed. 1995;301 Little Brown and Company, Boston.
23. Duma R.J. Pneumococcal pneumonia. Bennett J.C., Plum F. Cecil Textbook of Medicine. 20th ed. 1996;1569-1576 WB Saunders, Philadelphia.
24. Lipchik R.J. Pneumonia. Noble J., Green H. III, Levinson W., et al. Textbook of Primary Care Medicine. 2nd ed. 1996;1531-1540 Mosby, St. Louis.
25. Brown J. Acute infectious diseases of the lungs acute bronchitis and pneumonia . Fishman M.C., Hoffman A.R., Klausner R.D. Medicine. 4th ed. 1996;459-466 Lippincott-Raven, Philadelphia.
26. Butler J.C., Perlino C.A. Pneumonia caused by pyogenic bacteria. Hurst J.W. Medicine for the Practicing Physician. 4th ed. 1996;328-332 Appleton & Lange, Stamford, CT.
27. Schwartz B., O'Brien K.L. Streptococcal infections. Kelley W.N. Textbook of Internal Medicine. 3rd ed. 1997;1620 Lippincott-Raven, Philadelphia.
28. Chambers H.F. Infectious diseases bacterial and chlamydial . Tierney L.M. Jr, McPhee S.J., Papadakis M.A. Current Medical Diagnosis and Treatment 1997. 1997;1237-1238 Appleton & Lange, Stamford, CT.
29. Musher D.M. Pneumococcal infections. Fauci A.S., Braunwald E., Isselbacher K.J., et al. Harrison's Principles and Practice of Internal Medicine. 14th ed. 1998;869-875 McGraw-Hill, New York.
30. Knudsen J.D., Frimodt-Møller N., Espersen F. Experimental Streptococcus pneumoniae infection in mice for studying the correlation of in vitro and in vivo activities against pneumococci with various susceptibilities to penicillin. Antimicrob Agents Chemother. 39:1995;1253-1258.
31. Baquero F. Epidemiology and management of penicillin-resistant pneumococci. Curr Opin Infect Dis. 9:1996;372-379.
32. Bryan C.S., Stone W.J. "Comparably massive" penicillin G therapy in renal failure. Ann Intern Med. 82:1975;189-195.
33. Defining the public health impact of drug-resistant Streptococcus pneumoniae report of a working group . MMWR. 45:1996;1-20.
34. Hansman D., Bullen M.M. A resistant pneumococcus. Lancet. 2:1967;264-265. (Letter.).
35. Hansman D., Glasgow H., Sturt J., et al. Increased resistance to penicillin of pneumococci isolated from man. N Engl J Med. 284:1971;175-177.
36. Appelbaum P.C., Scragg J.N., Bowen A.J., et al. Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet. 2:1977;995-997.
37. Brewin A., Arango L., Hadley W.K., et al. High-dose penicillin therapy and pneumococcal pneumonia. JAMA. 230:1974;409-413.
38. Tuano S.B., Johnson L.D., Brodie J.L., et al. Comparative blood levels of hetacillin, ampicillin, and penicillin G. N Engl J Med. 275:1996;635-639.
39. Pallares R., Liñares J., Vadillo M., et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med. 333:1995;474-480.
40. Rahav G., Toledano Y., Engelhard D., et al. Invasive pneumococcal infections a comparison between adults and children . Medicine. 76:1997;295-303.
41. Song J.-H., Yang J.W., Peck K.R., et al. Spread of multidrug-resistant Streptococcus pneumoniae in South Korea. Clin Infect Dis. 25:1997;747-749.
42. Doern G.V., Brueggemann A., Holley H.P. Jr, Rauch A.M. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995 results of a 30-center national surveillance study . Antimicrob Agents Chemother. 40:1996;1208-1213.
43. Appelbaum P.C. Antimicrobial resistance in Streptococcus pneumoniae an overview . Clin Infect Dis. 15:1992;77-83.
44. Gross M.E., Giron K.P., Septimus J.D., et al. Antimicrobial activities of beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant pneumococci. Antimicrob Agents Chemother. 39:1996;1166-1168.
45. Gunnison J.B., Fraher M.A., Pelcher E.A., Jawetz E. Penicillin-resistant variants of pneumococci. Appl Microbiol. 16:1968;311-314.
46. Austrian R. Confronting drug-resistant pneumococci. Ann Intern Med. 121:1994;807-809.
47. Abraham E.P., Chain E., Fletcher C.M., et al. Further observations on penicillin. Lancet. ii:1941;177-188.
48. Goerner J.R., Geiger A.J., Blake F.T. Treatment of subacute bacterial endocarditis with penicillin report of cases treated without anticoagulant agents . Ann Intern Med. 23:1945;491-519.
49. Garrod L.P. Pharmacology of penicillin. Fleming A. Penicillin Its Practical Application . 1946;59-75 Butterworth, London.
50. Jawetz E. Dynamics of the action of penicillin on experimental animals observations on mice . Arch Intern Med. 77:1946;1-15.
51. Eagle H., Fleischman R., Musselman A.D. The bactericidal action of penicillin in vivo the participation of the host, and the slow recovery of the surviving organisms . Ann Intern Med. 33:1950;544-571.
52. Eagle H., Musselman A.D. The slow recovery of bacteria from the toxic effect of penicillin. J Bacteriol. 58:1949;475-490.
53. Boger W.P., Oritt J.E., Israel H.L., Flippin H.F. Procaine penicillin G in oil. I. Plasma concentrations preliminary observations on its use in pneumonia . Am J Med Sci. 215:1948;250-256.
54. Dowling H.F., Lepper M.H., Hirsh H.L. The treatment of pneumococcic pneumonia with large doses of repository penicillin compared with lower doses of penicillin a study of 686 patients . Am J Med Sci. 220:1950;17-22.
55. Barza M.J., Brusch J., Bergeron M.G., et al. Penetration of antibiotics into fibrin loci in vivo. III. Intermittent vs. continuous infusion and the effect of probenecid. J Infect Dis. 129:1974;73-78.
56. Bergeron M.G., Beauchamp D., Poirier A., Bastille A. Continuous vs. intermittent administration of antimicrobial agents tissue penetration and efficacy in vivo . Rev Infect Dis. 3:1981;84-97.
57. Plaut M.E., Hayes D.F. Inconstancy of "constantly" infused penicillin. JAMA. 209:1969;1530. (Letter.).
58. Eagle H., Fleischman R., Levy M. "Continuous" vs. "discontinuous" therapy with penicillin. The effect of the interval between injections on therapeutic efficacy. N Engl J Med. 248:1953;481-488.
59. Eagle H., Fleischman R., Musselman A.D. Effect of schedule of administration on the therapeutic efficacy of penicillin. Importance of the aggregate time penicillin remains at effectively bactericidal levels. Am J Med. 9:1950;280-299.
60. Craig W.A., Ebert S.C. Continuous infusion of β-lactam antibiotics. Antimicrob Agents Chemother. 36:1992;2577-2583.
61. Baaker-Woudenberg I.A.J.M., van den Berg J.C., Fontijne J.C., et al. Efficacy of continuous versus intermittent administration of penicillin G in Streptococcus pneumoniae pneumonia in normal and immunodeficient rats. Eur J Clin Microbiol. 3:1984;131-135.
62. Weinstein L., Lerner P.I., Chew W.H. Clinical and bacteriologic studies of the effect of "massive" doses of penicillin G on infections caused by gram-negative bacilli. N Engl J Med. 271:1964;525-533.
63. Fishman R.A. Blood-brain and CSF barriers to penicillin and related organic acids. Arch Neurol. 15:1966;113-124.
64. Walters I.N., Teychenne P.F., Claveria L.E., Calne D.B. Penicillin transport from cerebrospinal fluid. Neurology. 26:1976;1008-1010.
65. Caputo G.M., Appelbaum P.C., Liu H.H. Infections due to penicillin-resistant pneumococci clinical, epidemiologic, and microbiologic features . Arch Intern Med. 153:1993;1301-1310.
66. Bordon J, Vargas J, Ahkee S, Ramirez J. Early switch from intravenous to oral antibiotics in patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia. 35th Annual Meeting of the Infectious Diseases Society of America, San Francisco, CA; 1997. (Abstract 672.).
67. Heffron R. Pneumonia. 1939;Harvard University Press, Cambridge, MA.
68. Guidelines for the initial management of adults with community-acquired pneumonia diagnosis, assessment of severity, and initial antimicrobial therapy . Am Rev Respir Dis. 148:1993;1418-1426.
69. Fine M.J., Smith M.A., Carson C.A., et al. Prognosis and outcomes of patients with community-acquired pneumonia a meta-analysis . JAMA. 274:1995;134-141.
70. Bartlett J.G., Breiman R.F., Mandell L.A., File T.M. Community-acquired pneumonia in adults guidelines for management. The Infectious Disease Society of America . Clin Infect Dis. 26:1998;811-838.
71. Jernigan D.B., Cetron M.S., Breiman R.F. Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP) a strategy from the DRSP working group . JAMA. 275:1996;206-209.
72. The choice of antibacterial drugs. Med Lett. 38:1996;25-34.
73. Shlaes D.M., Gerding D.N., John J.F. Jr, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance guidelines for the prevention of antimicrobial resistance in hospitals . Clin Infect Dis. 25:1997;584-599.